1
CURRICULUM VITAE
Name: Renuka Malik, M.D.
Office Address:
University of Chicago
Department of Radiation and Cellular Oncology
5758 S. Maryland Ave, MC 9006
Chicago, IL 60637
E-Mail: rmalik@radonc.uchicago.edu
Medical License/Certification:
08/2010
State of Illinois, 036125277
08/2010
DEA, FM1951424
06/2011
Board Certification in Radiation Oncology (American Board of Radiology)
Education:
1998-2001
University of Illinois at Chicago
Chicago, IL
Guaranteed Pre-Professional Honors Program in Medicine
(Seven-year program with direct admission into medical school from high school)
B.A. Philosophy; Minor: Biology
Summa Cum Laude
2001-2005
University of Chicago Pritzker School of Medicine
Doctor of Medicine (M.D.)
Chicago, IL
Postdoctoral Training:
Internship
2005-2006
Resurrection Medical Center
Transitional Year
Chief Resident
Chicago, IL
Residency
2006-2010
University of Chicago Hospitals
Department of Radiation and Cellular Oncology
Co-Chief Resident (2008-2009)
Chicago, IL
Externships
02/2009
Princess Margaret Hospital
Department of Radiation Oncology
Toronto, Canada
Positions and Appointments:
2
8/2010-present
Clinical Instructor, Department of Radiation Oncology and Cellular Oncology
University of Chicago, Chicago, IL
4/2012-present
Department of Radiation and Cellular Oncology Quality Chair
Scientific and Medical Societies:
2006-present
American Society of Therapeutic Radiology and Oncology
Honors and Awards:
1999, 2000
Illinois State General Assembly Scholar (Two-time full tuition scholarship recipient)
2000
Chicago Circle Physics Scholar (Awarded to top introductory physics student)
2000
Rhodes Scholarship Competition, Illinois State Finalist
(Selected as one of nine state finalists)
2001
University of Illinois Honors College Distinguished Senior Student Award
(Awarded to one graduating Honors College student)
2001
Avery Brundage Scholarship for Academics and Amateur Athletics
2001
Honors Council Award
2001
University of Illinois Alumni Association Leadership Award
2001
Chancellor’s Student Service Award
2001
Phi Eta Sigma (Scholarship Recipient)
2001
Phi Beta Kappa, Phi Kappa Phi
2005
University of Chicago, School of Medicine Fentress Research Scholar Award
2005
University of Chicago, Department of Radiation and Cellular Oncology Senior
Medical Student Award
2010
American Brachytherapy Society Nucletron HDR Fellowship Recipient
(Awarded to 10 Radiation Oncology residents annually)
Presentations:
1997
Malik R, Pack G. “Twisting and Turning of DNA: Nucleosome Modeling”
Oral Presentation, University of Illinois College of Medicine Summer Research
Internship Forum, Rockford, IL
3
2002
Malik R, Lavey R. “Late Effects of Cranial or Spinal Radiation Therapy on
Growth, Thyroid, and Anti-Diuretic Hormones.”
Oral Presentation, Children’s Hospital of Los Angeles, Los Angeles, CA
2003
Malik R, Lavey R. “Late Effects of Cranial or Spinal Radiation Therapy on
Growth, Thyroid and Anti-Diuretic Hormones.”
Poster, Pediatric Academic Societies Annual Meeting, Seattle, WA
2004
Malik R, Oh J, Roeske JC, Mundt AJ. “Resident Education in IntensityModulated Radiation Therapy.”
Oral Presentation, American Society for Therapeutic Radiology and Oncology
(ASTRO) Annual Meeting, Outcomes Scientific Session, Philadelphia, PA
2005
Malik R, Mell L, Mundt AJ. “Effect of Amifostine on Response Rates in Locally
Advanced Non-Small-Cell Lung Cancer Patients treated on randomized controlled
trials: a Meta-Analysis.”
Oral Presentation, American Society for Therapeutic Radiology and Oncology
(ASTRO) Annual Meeting, Outcomes Scientific Session, Denver, CO
2006
Malik R, Mell L, Mundt AJ. “Effect of Amifostine on Response Rates in Locally
Advanced Non-Small-Cell Lung Cancer Patients treated on randomized controlled
trials: a Meta-Analysis.”
Oral Presentation, University of Chicago Pritzker School of Medicine, Fentress
Research Forum, Chicago, IL
2007
Malik R, Cloutier D, Liauw SL. “Can External Beam Radiation Therapy for
Prostate Carcinoma Help Improve Urinary Symptoms in Men with High IPSS
Scores?”
Oral Presentation, American Society for Therapeutic Radiology and Oncology
(ASTRO) Annual Meeting, Quality of Life Scientific Session, Los Angeles, CA
2008
Malik R, Jani AB, Liauw SL. “PSA ‘Halving-Time’ during Neoadjuvant ADT
and Prior to Radiotherapy is Associated with Biochemical Control in Men with
Localized Prostate Cancer.”
Oral Presentation, American Society for Therapeutic Radiology and Oncology
(ASTRO) Annual Meeting, GU Scientific Session, Boston, MA
2010
Malik R, Correa D, Liauw SL. "The Influence of Time to Radiotherapy after
Biopsy on Biochemical Control in Men with Localized Prostate Cancer."
Poster Presentation, American Radium Society Meeting, Cancun, Mexico
2010
Khodarev NN, Pitroda SP, Wakim BT, Golden D, Beckett MA, Mauceri HJ,
Sutton HG, Perakis S, Malik R, Wietholt C, Pelizzari C, Chen C, Weichselbaum
RR. “STAT1-dependent Expression of Genes and Proteins Involved in Energy
Metabolism Links Tumor Growth and Radioresistance to the Warburg Effect and
Predicts Poor Prognosis in Cancer Patients” Poster Presentation, American
Association for Cancer Research Meeting (AACR), 04/2010
4
2010
Malik R, Haraf DJ, Pederson AW, Choe KS, Witt ME, Salama JK, Cohen EE,
Blair EA, Stenson KM, Cohen EE, Vokes, EE. “Impact of Induction
Chemotherapy on Treatment Outcomes in Advanced Head and Neck Carcinoma
Patients treated with Concurrent Chemotherapy and Hyperfractionated
Radiotherapy.”
Poster Presentation, American Society for Therapeutic Radiology and Oncology
(ASTRO) Annual Meeting, San Diego, CA
2011
Khodarev N; Pitroda S; Sood R; Khan R; Filippo M; Gutt R; Perakis S; Darga T;
Malik R; Pederson A; Weichselbaum R. “Ionizing Radiation activates IFN
signaling in tumor cells”
Poster Presentation, American Association for Cancer Research Annual Meeting
2011
Hasselle M, Salama JK, Tye K, Liauw SL, Weichselbaum RR, Malik R.
“Patterns of Progression following Hypofractionated Image-guided Radiotherapy
to Abdominal Nodes in Oligometastatic Patients with Abdominopelvic Primary
Tumors.” Poster Presentation, American Society for Therapeutic Radiology and
Oncology (ASTRO), 2011
2011
Rudra S, Malik R, Ranck MC, Hasselle M, Golden D, Weichselbaum RR, Salama
JK. “Hypofractionated image-guided radiation therapy for adrenal
oligometastases.” Oral Presentation, Radiological Society of North America
(RSNA) 2011.
Invited Presentations:
2011
“Update on Clinical Trials for Patients with Advanced Distal Esophagus/GEJ
Carcinoma.” Oral Presentation, 3rd Annual Gastrointestinal University of
Chicago Cancer Symposium, Chicago, IL
2012
“Locally Advanced Distal Esophagus/GEJ Carcinoma.” Oral Presentation,
Chicago Radiologic Society, Rush University, Chicago, IL
Publications:
1. Malik R, Oh JL; Roeske JC; Mundt AJ. “Survey of Resident Education in Intensity-Modulated
Radiation Therapy.” Technol Cancer Res Treat 2005; 4(3): 303-309.
2. Mell LK, Malik R, Komaki R, Movsas B, Swann SR; Langer C; Antonadou D; Koukourakis M;
Mundt AJ. “Effect of Amifostine on Response Rates in Locally Advanced Non-Small-Cell Lung
Cancer Patients Treated on Randomized Controlled Trials: a Meta-Analysis.” Int J Radiat Oncol
Biol Phys 2007; 68(1): 111-118.
3. Malik R, Jani AB, Liauw SL. “PSA ‘Halving-Time’ during Neoadjuvant Androgen Deprivation
Therapy and Prior to Radiotherapy is Associated with Biochemical Control.” Int J Radiat Oncol
Biol Phys 2011; 79(4): 1022-1028.
5
4. Malik R, Jani AB, Liauw SL. “Can External Beam Radiotherapy for Prostate Cancer Help
Improve Urinary Symptoms in Men With High IPSS Scores?” Int J Radiat Oncol Biol Phys
2011; 80(4): 1080-1086.
Article Selected as Feature Article for Online CME
5. Shumway D; Corbin K; Salgia R; Hoffman P; Villaflor V; Malik RM; Maitland M; Haraf DJ;
Vigneswaren W; Connell PP; Ferguson M; and Salama JK. “Pathologic Response Rates
Following Definitive Dose Image-Guided Chemoradiotherapy Followed by Resection for
Locally Advanced Non-small Cell Lung Cancer.” Lung Cancer 2011 Dec; 74(3): 446-50.
6.
Salama JK; Hasselle M; Chmura SJ; Malik R; Mehta N; Yenice KM; Villaflor V; Stadler WM;
Hoffman P; Cohen E; Connell P; Haraf DJ; Vokes EE; Hellman S; Weichselbaum RR
“Stereotactic body radiotherapy (SBRT) for multi-site extracranial oligometastases: Final
report of a dose escalation trial in patients with one to five sites of metastatic disease.”
Cancer 2012 Jun 1; 118(11): 2962-70.
7.
Lussier Y, Xing HR, Salama JK, Khodarev NN, Huang Y, Hasselle MD, Zhang Q, Yang X,
Khan SA, Malik R, Darga TE, Fan H, Perakis S, Filippo M, Lee Y, Posner MC, Chmura
SJ, Hellman S, Weichselbaum RR. “MicroRNA expression characterizes oligometastases.”
PLoS One 2011; 6(12): e28650
Abstracts:
1. Malik R, Lavey R. “Late Effects of Cranial or Spinal Radiation Therapy on Growth, Thyroid,
and Anti-Diuretic Hormones.” Proceedings of Pediatric Research, 2003
2. Malik, R, Oh JL; Roeske JC; Mundt AJ. “Resident education in Intensity-Modulated Radiation
Therapy (IMRT).” Int J Radiat Oncol Biol Phys 2004; 60: S146
3. Malik R, Mell LK, Mundt AJ. “Meta-Analysis of the Effect of Amifostine on Response Rates
in Advanced Non-Small Cell Lung Cancer Patients Treated on Randomized Trials.” Int J
Radiat Oncol Biol Phys 2005; 63: S117
4. Malik R, Jani AB, Cloutier D, Liauw SL. “Can External Beam Radiotherapy for Prostate
Cancer Help Improve Urinary Symptoms in Men With High IPSS Scores?” Int J Radiat Oncol
Biol Phys 2007; 69: S30
5. Malik R, Jani AB, Liauw SL. “PSA ‘Halving-Time’ during Neoadjuvant Androgen
Deprivation Therapy and Prior to Radiotherapy is Associated with Biochemical Control.” Int J
Radiat Oncol Biol Phys 2008; 72: S56
6. Malik R, Correa D, Liauw SL. "The Influence of Time to Radiotherapy after Biopsy on
Biochemical Control in Men with Localized Prostate Cancer."
American Radium Society Meeting, 05/2010.
7. Malik R, Haraf DJ, Pederson AW, Choe KS, Witt ME, Salama JK, Cohen EE, Blair EA,
6
Stenson KM, Cohen EE, Vokes, EE. “Impact of Induction Chemotherapy on Treatment
Outcomes in Advanced Head and Neck Carcinoma Patients treated with Concurrent
Chemotherapy and Hyperfractionated Radiotherapy.” American Society for Therapeutic
Radiology and Oncology (ASTRO) 11/2010
8. Khodarev N, Pitroda S, Sood R, Khan R, Filippo M, Gutt R, Perakis S, Darga T, Malik R,
Pederson A, Weichselbaum R. “Ionizing Radiation activates IFN signaling in tumor cells”
American Association for Cancer Research Annual Meeting (AACR), 2011
9. Hasselle M, Salama JK, Tye K, Liauw SL, Weichselbaum RR, Malik R. “Patterns of
Progression following Hypofractionated Image-guided Radiotherapy to Abdominal Nodes in
Oligometastatic Patients with Abdominopelvic Primary Tumors.” American Society for
Therapeutic Radiology and Oncology Meeting (ASTRO), 2011
10. Rudra S, Malik R, Ranck MC, Hasselle M, Golden D, Weichselbaum RR, Salama JK.
“Hypofractionated image-guided radiation therapy for adrenal oligometastases.” Radiological
Society of North America (RSNA) 2011.
Prospective Research Ongoing:
1. Phase I Study Investigating Use of Statin Therapy to Prevent Radiation Pneumonitis and Fibrosis
after Definitive Treatment for Non-Small Center Lung Cancer
Investigators: Dr. Sonali Rudra, Dr. Renuka Malik (PI), Dr. Joe Garcia, Dr. Ralph Weichselbaum
Study Proposal Selected for ASCO/AACR Workshop: Methods in Clinical Cancer Research 2011
Status: Non-Active
2. A Long Term Investigation of Radiation Treatment in Lung Cancer Patients, Protocol: 16057A
Role: Principal Investigator
Prospective database is designed to assess long-term outcomes for lung cancer patients treated with
definitive radiotherapy. Lung texture analysis with dose mapping is being conducted in
collaboration with radiology to assess for early architectural changes correlated with symptomatic
pneumonitis and to determine if these early changes lead to late fibrosis.
Status: Active
Committees:
2005
Selection Committee for Medical School applicants
University of Chicago Pritzker School of Medicine
2007-2011
Selection Committee for Radiation Oncology Residency applicants
University of Chicago, Department of Radiation and Cellular Oncology
2011-2012
Member of Technical Expert Panel for “Local Therapies for Localized Non-Small Cell
7
Lung Cancer” BlueCross Blue Shield Technology Evaluation Center
Non-Academic Recognition:
1. Chicago Marathon (5th place female age-division [19 & under], top 5% female finishers), 1999
2. Chicago Half-Marathon (2nd place female age-division [19 & under]), 1999
3. Chicago Distance Classic 20K Run (1st place female age-division [19 & under]), 1999